- $3.41bn
- $5.01bn
- $990.34m
- 83
- 44
- 65
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 965 | 875 | 781 | 846 | 990 |
Cost of Revenue | |||||
Gross Profit | 509 | 498 | 423 | 426 | 541 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 818 | 866 | 665 | 724 | 747 |
Operating Profit | 147 | 9.09 | 117 | 121 | 244 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 58.5 | -86 | 39 | 60.6 | 142 |
Provision for Income Taxes | |||||
Net Income After Taxes | 97.6 | -68.4 | 28.2 | 44.3 | 105 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 97.3 | -68.4 | 28.2 | 44.3 | 105 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 96 | -69.8 | 27 | 42.9 | 103 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.893 | 0.318 | 0.15 | 0.189 | 0.685 |
Dividends per Share |